TRDA
Entrada Therapeutics Inc.
$5.47
-$0.18(-3.19%)
53
Overall
80
Value
45
Tech
36
Quality
Market Cap
$213.39M
Volume
146.57K
52W Range
$4.93 - $21.79
Target Price
$18.50
EPS Estimates Overview
| Current Quarter | $-1.04 | Next Quarter | $-1.08 |
| Current Year | $-3.59 | Next Year | $-4.58 |
| QoQ Growth | -3.8% | YoY Growth | -27.6% |
| 3Y EPS CAGR | +22.0% | Target Price | $18.50 |
| Consensus | Buy | Upside | +238.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRDA | $5.47 | -3.2% | 146.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Entrada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW